BridgeBio Oncology Therapeutics, Inc. (BBOT)
NASDAQ: BBOT · Real-Time Price · USD
8.80
+0.01 (0.11%)
At close: Apr 28, 2026, 4:00 PM EDT
8.97
+0.17 (1.93%)
After-hours: Apr 28, 2026, 6:08 PM EDT
BBOT Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| FY 2025 | FY 2024 | FY 2023 |
| Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 |
| Selling, General & Admin | 24.62 | 7.76 | 8.49 |
| Research & Development | 121.2 | 73.11 | 56.29 |
| Operating Expenses | 145.82 | 80.86 | 64.77 |
| Operating Income | -145.82 | -80.86 | -64.77 |
| Interest & Investment Income | 11.34 | 6.38 | 0.07 |
| Other Non Operating Income (Expenses) | 0.43 | 0.21 | - |
| Pretax Income | -134.04 | -74.28 | -64.7 |
| Net Income | -134.04 | -74.28 | -64.7 |
| Net Income to Common | -134.04 | -74.28 | -64.7 |
| Shares Outstanding (Basic) | 31 | 0 | 0 |
| Shares Outstanding (Diluted) | 31 | 0 | 0 |
| Shares Change (YoY) | 241276.23% | -89.66% | - |
| EPS (Basic) | -4.30 | -5756.41 | -518.73 |
| EPS (Diluted) | -4.30 | -5756.41 | -518.73 |
| Free Cash Flow | -114.5 | -55.08 | -52.49 |
| Free Cash Flow Per Share | -3.68 | -4268.47 | -420.87 |
| EBITDA | -145.54 | -80.66 | -64.68 |
| D&A For EBITDA | 0.28 | 0.21 | 0.09 |
| EBIT | -145.82 | -80.86 | -64.77 |
Source: S&P Capital IQ. Standard template.
Financial Sources.